This highly interactive symposium addresses reducing Atherosclerotic Cardiovascular Disease (ASCVD) event risk with adjunctive therapies to statin use.  Work through complex issues caring for patients with elevated atherogenic cholesterol and triglycerides and diabetes, many of whom have been sub-optimally managed and continue to be at risk of advancing cardiovascular disease.

Approved for 1.0 AOA Category 1-B CME credits.
Cost: Members/Non-Members Free
Course Expires: December 31, 2020

Category 1B